Indication

Cystic fibrosis with homozygous F508del mutation in CFTR gene

Cystic fibrosis with a homozygous F508del mutation in the CFTR gene is an autosomal recessive, multi-organ genetic disorder characterized by the presence of two identical copies of the class II deletion of phenylalanine at position 508 in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene. Read more about Cystic fibrosis with homozygous F508del mutation in CFTR gene

5 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Cystic fibrosis with homozygous F508del mutation in CFTR gene therapies.

Showing 1–5 of 5 drugs

ORKAMBI (lumacaftor/ivacaftor)

CYSTIC FIBROSIS TRANSMEMB. CONDUCT. REG. (CFTR) POTENTIATORS·CYSTIC FIBROSIS WITH HOMOZYGOUS F508DEL MUTATION IN CFTR GENE
VERTEX PHARMACEUTICAL

SYMDEKO (tezacaftor/ivacaftor)

CYSTIC FIBROSIS TRANSMEMB. CONDUCT. REG. (CFTR) POTENTIATORS·CYSTIC FIBROSIS WITH HOMOZYGOUS F508DEL MUTATION IN CFTR GENE·+1
VERTEX PHARMACEUTICAL

ORKAMBI (lumacaftor/ivacaftor)

CYSTIC FIBROSIS TRANSMEMB. CONDUCT. REG. (CFTR) POTENTIATORS·CYSTIC FIBROSIS WITH HOMOZYGOUS F508DEL MUTATION IN CFTR GENE
VERTEX PHARMACEUTICAL
Filter & compare in the drug finder →Opens the drug finder with Cystic fibrosis with homozygous F508del mutation in CFTR gene preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cystic fibrosis with homozygous F508del mutation in CFTR gene.

Cystic fibrosis with a homozygous F508del mutation in the CFTR gene is an autosomal recessive, multi-organ genetic disorder characterized by the presence of two identical copies of the class II deletion of phenylalanine at position 508 in the cystic fibrosis transmembrane conductance regulator (*CFTR*) gene.

This specific genotype leads to abnormal protein folding and premature endoplasmic reticulum degradation, severely depleting functional chloride and bicarbonate channels at epithelial apical surfaces across the respiratory, gastrointestinal, pancreatic, hepatobiliary, and reproductive tracts.

The resulting defect impairs epithelial ion and fluid transport, driving the accumulation of thick, dehydrated secretions that precipitate chronic airway obstruction, recurrent bronchopulmonary infections, bronchiectasis, and progressive exocrine pancreatic insufficiency.

Personalize your experience

Follow Cystic fibrosis with homozygous F508del mutation in CFTR gene and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it